Endologix Inc. Reports 25% Third Quarter 2011 Revenue Growth

October 28, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

IRVINE, Calif., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2011.

Twitter
LinkedIn
Facebook
Email
Print

Earnings